Financhill
Back

Regeneron Pharmaceuticals 10K Form

Buy
65

REGN
Regeneron Pharmaceuticals

Last Price:
1,069.48
Seasonality Move:
8.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive REGN News And Ratings

See the #1 stock for the next 7 days that we like better than REGN

REGN Financial Statistics

Sales & Book Value

Annual Sales: $13.12B
Cash Flow: $1.35B
Price / Cash Flow: 31.04
Annual Sales: $244.96
Price / Book: 4.37

Profitability

EPS (TTM): 33.85000
Net Income (TTM): $3.86B
Gross Margin: $11.3B
Return on Equity: 15.38%
Return on Assets: 12.03%

Regeneron Pharmaceuticals Earnings Forecast

Key Regeneron Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 34 years for REGN is 86.16%.
  • The Selling, General & Administrative Expenses for REGN have been equal to 20.06% of Gross Profit Margin.
  • The Research & Development expenses have been 33.84% of Revenue.
  • The Interest Expense is 1.85% of Operating Income.
  • The Net Earning history of REGN is 30.14% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 18 years.

Regeneron Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: REGN
CUSIP: 75886F
Website: regeneron.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 5.27
Quick Ratio: 4.4

Price-to-Earnings

Trailing P/E Ratio: 30.77
Forward P/E Ratio: 22.75

REGN Technical Analysis vs Fundamental Analysis

Buy
65
Regeneron Pharmaceuticals (REGN) is a Buy

Is Regeneron Pharmaceuticals a Buy or a Sell?